10-2与24-2视野检查定性评估检测青光眼中心视野异常
这项横断面研究纳入523只青光眼视神经外观或高眼压眼和107只健康眼,由4名青光眼专家定性评估10-2与24-2中央12个对应位点(C24-2)检测中心视野异常的概率。在95%特异性下,两种检查的敏感度无显著差异,提示10-2更密集采样并未显著改善专家定性检测中心视野异常的能力。
要点
- 95%特异性下10-2与C24-2定性评估敏感度无显著差异。
- 10-2的模式标准差敏感度在3名评估者中显著高于其定性评估。
- C24-2的模式标准差与定性评估敏感度相似。
核心结论
- 10-2与C24-2检测中心视野异常的定性评估表现相似,10-2更密集采样未显著改善检测。
- 不应据此认为10-2无用,但将其纳入青光眼常规标准诊疗前需明确其效用。
研究设计与样本
- 横断面研究,纳入青光眼视神经外观或高眼压眼523只和健康眼107只。
- 由4名青光眼专家对10-2和C24-2视野结果进行定性分级,评估中心视野异常概率。
临床怎么用
- 专家定性评估10-2与C24-2对中心视野异常的检测效能相似,选择检查时需结合临床场景。
- 10-2的模式标准差可能较其定性评估提供更高的敏感度,可辅助判读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To examine whether glaucomatous central visual field abnormalities can be more effectively detected using a qualitative, expert evaluation of the 10-2 test compared with the topographically corresponding central 12 locations of the 24-2 test (C24-2). DESIGN: Cross-sectional study. METHODS: Eyes with a glaucomatous optic nerve appearance or ocular hypertension (n = 523) and healthy eyes (n = 107) were included as cases and control subjects, respectively. The 10-2 and C24-2 visual field results of all eyes were graded by 4 glaucoma specialists for the probability that central visual field abnormalities were present. RESULTS: The sensitivity of the 10-2 and C24-2 tests for detecting the cases at 95% specificity were not significantly different (e.g., 32.2% and 31.4%, respectively, for grader 1, P = .87; all graders P ≥ .25). At 95% specificity, the pattern standard deviation values from these tests had a similar sensitivity to the qualitative evaluation for the C24-2 test for all graders (P ≥ .083), but it had a significantly higher sensitivity than the qualitative evaluation for the 10-2 test for 3 graders (P ≤ .016). CONCLUSIONS: The similarity in performance of the 10-2 and C24-2 test suggests that the increased sampling density of the former does not significantly improve the detection of central visual field abnormalities, even when based on expert assessment. These findings should not be taken to mean that the 10-2 test is not useful, but it underscores the need for its utility to be clearly established before incorporating it as routine glaucoma standard of care.
引用
- Orbach A, Ang GS, Camp AS, et al. Qualitative Evaluation of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma. Am J Ophthalmol. 2021. PMID: 33626360. doi:10.1016/j.ajo.2021.02.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。